Lower Urinary Tract Symptoms Weekly

December 14, 2025

Videos

Peer-to-Peer Clinical Conversations

Analysis of URPS Fellowship Paths: Comparing Training Duration, Accreditation, and Practice Outcomes - David Ginsberg

Joseph Prijdekker

David Ginsberg discusses urology-based URPS fellowships with Alan Wein.

Bladder-Centric Focus in BPH: Early Triage and a Five-Stage Model - Wayne Kuang

Wayne Kuang discusses his ManVsProstate initiative with Alan Wein, emphasizing bladder health preservation in BPH.

Articles

Editor Selected Abstracts and Commentaries

Nocturia

Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI-RS 2025.

Urinary Incontinence

Exploring the prevalence of urinary incontinence in multi-ethnic refugee women in Maricopa county, Arizona.

Chair-Based Magnetic Pelvic Floor Stimulation and Female Sexual Function in Women with Urinary Incontinence: A Systematic Review.

Stress Incontinence

Strategy of Delayed Midurethral Sling Surgery for Pelvic Organ Prolapse with Stress Urinary Incontinence after Laparoscopic Lateral Abdominal Wall Suspension.

Failure Rate, Time to Failure, and Associated Risk Factors: Polyacrylamide Hydrogel Injection for the Treatment of Stress Urinary Incontinence in a Large Cohort.

Trends in the Treatment of Stress Urinary Incontinence in a Tertiary Care Center After the Introduction of Polyacrylamide Hydrogel.

Interstitial Cystitis

Sacral Nerve Stimulation and Chronic Bladder Pain: Meta-Analysis.

How Can We Make Progress in the Management of Bladder Pain Syndrome? ICI-RS 2025.

Urologic chronic pelvic pain syndrome 3-year symptom trajectories: the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Symptom Patterns Study.

Overactive Bladder

Effects of Angelica archangelica Extract on Overactive Bladder: A Pilot Randomized Controlled Trial.

Phenotyping Overactive Bladder-Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI-RS 2025.

Use and Persistence of Beta 3-Adrenoceptor Agonists for the Treatment of Overactive Bladder.

Antimuscarinic Use and Dementia Incidence in Women With Overactive Bladder.

BPH - Benign Prostatic Enlargement

TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progression.

Introduction of a Structured Reporting Protocol and Surgical Checklist for Rezum Water Vapor Therapy (VAPOR-SRP).

Do patients Rezum medications?-a real-world analysis of medical retreatment after water vapor thermal therapy.

Thulium fibre laser endoscopic enucleation of the prostate (THUFLEP) learning curve assessment: A retrospective analysis of the experience of a single surgeon.

FDA Approves the ProVee System - The First of a New Generation of Prostatic Urethral Stents for Treatment of BPH

Benign Prostatic Hyperplasia Patient Outcomes in Various Robotic-Assisted Simple Prostatectomy Approaches vs Prostate Enucleation in Large Prostates: A Systematic Review and Bayesian Network Meta-Analysis.

A Narrative Review of New Emerging Urological Interventions for Benign Prostatic Hyperplasia: HoLEP, Rezum, and Aquablation.

Intermittent Catheters

Characterizing Urine and Sediment in Individuals with Lower Urinary Tract Dysfunction Utilizing Intermittent Catheters.

Urinary Tract Infection – CAUTIs

Evaluating nursing interventions to prevent catheter-associated urinary tract infection in ICU patients: a quasi-experimental study.

Neurogenic bladder

Therapeutic outcomes and predictive factors of intradetrusor onabotulinumtoxinA for neurogenic detrusor overactivity (NDO) associated with spinal cord lesion.

Save the Bladder: Continent Urinary Diversion as Best Practice for Patients With Refractory Neurogenic Lower Urinary Tract Dysfunction.

Managing Neurogenic Bladder with a Suprapubic Catheter vs Urethral Foley – Which is Best?

Lower Urinary Tract Symptoms

Impact of COVID-19 and Vaccination on Lower Urinary Tract Symptoms: Insights From a Prospective Cohort Study.

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC